A theme covering declines in revenue and profit in the wholesale business for prescription pharmaceuticals and other medical products, due to factors including National Health Insurance drug price revisions, the spread of infections and intensifying price competition. It concerns deterioration specific to the wholesale business, rather than the pharmaceutical manufacturing and marketing, active pharmaceutical ingredient sales or overall pharmaceutical market.